CASC
SGMO

Coppell Advisory Solutions Corp’s SANGAMO THERAPEUTICS INC SGMO Stock Holding History

Coppell Advisory Solutions Corp’s Portfolio SGMO Stock Details SGMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-200
Closed -$628 – 913
2022
Q4 		$628 Buy
+200
New +$776 ﹤0.01% 992

Other funds holding SGMO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Coppell Advisory Solutions Corp's SGMO Position: Q1 2023 in Review

Coppell Advisory Solutions Corp sold out of SANGAMO THERAPEUTICS INC (SGMO) in Q1 2023, closing a stake of 200 shares — an estimated $628 sold.

Coppell Advisory Solutions Corp first reported a position in SGMO in Q4 2022 and held it in 1 quarter. The position peaked at $628 in Q4 2022. 179 funds tracked by Wall St. Rank hold SGMO as of Q1 2023.

  • Coppell Advisory Solutions Corp reported no remaining SANGAMO THERAPEUTICS INC position as of Q1 2023 after selling out during the quarter.
  • Coppell Advisory Solutions Corp sold 200 SANGAMO THERAPEUTICS INC shares in Q1 2023, an estimated $628.
  • Coppell Advisory Solutions Corp first reported a position in SANGAMO THERAPEUTICS INC in Q4 2022 and held it in 1 quarter.
  • Coppell Advisory Solutions Corp's SANGAMO THERAPEUTICS INC position peaked at $628 in Q4 2022.
  • 179 funds tracked by Wall St. Rank held SANGAMO THERAPEUTICS INC as of Q1 2023.

Based on Coppell Advisory Solutions Corp's 13F filing for Q1 2023, filed 10 May 2023.